Podbit · The Peter Attia Drive
BPC-157 fails every test: no clear mechanism, no human RCTs after 30 years, unknown pharmacokinetics, and biologically plausible cancer concerns via VEGF and nitric oxide pathways. The scientist who discovered it has refused to publish the screening method. That's not a drug — it's a story.
Where this was said
At 14:15 · chapter starts 14:00
Peter applies his framework to BPC-157 — the poster child, he says, for everything that should make you skeptical of a peptide. On mechanism: the alleged parent protein has never been fully characterized, and the discoverer has refused to publish the screening method used to identify the compound, saying 'if you have your own child, you want it to be yours forever.' That's not missing data; that's deliberately withheld data — the scientific equivalent of 'trust me, bro.' Several mechanisms involving VEGF and nitric oxide have been proposed but none established in humans, and the primary receptor or target remains unknown. On human evidence: over 80% of the published literature comes from a single academic group with IP and commercial interests in the molecule, and independent replication is astonishingly thin. [1] — Peter Attia "BPC-157 fails every test: no clear mechanism, no human RCTs after 30 years, unknown pharmacokinetics, and biologically plausible cancer con…" 14:15 After approximately three decades of claims, there are no published peer-reviewed human RCTs. On safety and pharmacokinetics: human bioavailability is unknown, dosing protocols are guesses, and long-term risks have not been adequately studied. The risk-benefit calculation is also concerning: if BPC-157 truly stimulates VEGF and nitric oxide pathways as proponents claim, those are exactly the pathways that potentiate tumor biology. The conclusion: BPC-157 belongs firmly in Bucket 1.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Despite approximately 30 years of promotion and dozens of claimed benefits, there are no published peer-reviewed human randomized controlled trials demonstrating BPC-157 accelerates healing.
If BPC-157 meaningfully stimulates VEGF and nitric oxide pathways as proponents claim, those same pathways also potentiate tumor biology — a risk proponents fail to take seriously.
Spike your cortisol in the first 1–3 hours of your day — with sunlight, hydration, exercise, or caffeine — and you set up elevated mood, focus, and stress resilience for the rest of the day. Miss that spike and you get a flat cortisol curve: brain fog, poor learning, and bad sleep. The bookend is equally important: dim lights, no caffeine, and wind down the final hour.
Bottom-up impulses — just eat the cookie, keep scrolling — are driven by deep brain structures. Top-down prefrontal control is the thing that lets you wait, learn, and grow. Every small act of choosing the harder thing, from picking up trash to doing the workout you dread, greases that top-down circuit — and it transfers to everything else.
A Washington University in St. Louis study found that the attention-improvement effects of Ritalin are effectively equal to a great night's sleep. Stimulants also stunt growth and reduce sleep quality. The new direction is combining lower medication doses with genuinely better sleep — not replacing sleep with pharmacology.
Two big inhales through the nose, then a full exhale to empty — that's the physiological sigh. It fires a specific vagal pathway to slow your heart rate, offload CO2, and tip the autonomic nervous system toward calm instantly. Doing just 10 deliberate exhales throughout the day measurably elevates HRV by nighttime.
Presence isn't a state you fall into — it's something you actively produce by anchoring perception to the immediate environment. Ask 2–3 trivially specific questions about your surroundings (how many cans, what does it smell like) to pull your brain out of past/future mode. Then deliberately choose what to think or say next. That's it.
Acknowledge the thing, feel all of it, uncouple the emotion from the memory, then transmute the experience into something meaningful. Most people stall at step 2 — feeling the feelings — and never reach uncoupling. An entire generation is stuck there, confusing emotional processing for healing. Moving through all four is the actual path out.
Nicotine creates a uniquely alert-and-calm state ideal for learning — but only at low doses used occasionally. If you're using 3–6 mg pouches multiple times a day, you're not getting a cognitive enhancement, you're just rescuing yourself from withdrawal. For a genuine performance effect, use it once or twice per week at most.
Two injections of BPC-157 (100–200 mcg) eliminated shoulder pain Huberman couldn't shift for months. The peptide pinealon gave him 2.5–3 hours of REM sleep inside 6 hours — an effect that persisted into subsequent nights and scaled down to just once per week. Neither is in the book because the human data aren't there yet, but the animal evidence is strong.
Long, slow cardio builds capillary networks and mitochondrial richness; high-intensity intervals push VO2 max. You don't need huge volumes of either. Huberman's protocol: one 45–60 minute long slow session, one near-maximal effort HIIT session (Airdyne 20-on/10-off for 6–8 rounds), and one medium 30-minute effort per week. That's the complete cardio picture.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.